Nature Communications (Aug 2022)

Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes

  • Samah Hayek,
  • Yatir Ben-shlomo,
  • Noa Dagan,
  • Ben Y. Reis,
  • Noam Barda,
  • Eldad Kepten,
  • Alina Roitman,
  • Shachar Shapira,
  • Shlomit Yaron,
  • Ran D. Balicer,
  • Doron Netzer,
  • Alon Peretz

DOI
https://doi.org/10.1038/s41467-022-32253-9
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 5

Abstract

Read online

REGEN-COV is a SARS-CoV-2 combined monoclonal antibody treatment which has been shown to be effective in randomised controlled trials. Here, the authors assess its real-world effectiveness using data from Israel during the Delta wave and find that it reduced the risk of hospitalisation, severe disease and death.